Journal
DEVELOPMENTAL DYNAMICS
Volume 244, Issue 2, Pages 99-109Publisher
WILEY
DOI: 10.1002/dvdy.24242
Keywords
Tacstd2; EpCAM; cell proliferation; cell migration; lung development; cancer
Categories
Funding
- National Health and Medical Research Council
- Victorian Government's Operational Infrastructure Support Program
Ask authors/readers for more resources
Background Trop2 was first discovered as a biomarker of invasive trophoblast cells. Since then most research has focused on its role in tumourigenesis because it is highly expressed in the vast majority of human tumours and animal models of cancer. It is also highly expressed in stem cells and in many organs during development. We review the multifaceted role of Trop2 during development and tumourigenesis, including its role in regulating cell proliferation and migration, self-renewal, and maintenance of basement membrane integrity. We discuss the evolution of Trop2 and its related protein Epcam (Trop1), including their distinct roles. Mutation of Trop2 leads to gelatinous drop-like corneal dystrophy, whereas over-expression of Trop2 in human tumours promotes tumour aggressiveness and increases mortality. Although Trop2 expression is sufficient to promote tumour growth, the surprising discovery that Trop2-null mice have an increased risk of tumour development has highlighted the complexity of Trop2 signaling. Recently, studies have begun to identify the mechanisms underlying TROP2's functions, including regulated intramembrane proteolysis or specific interactions with integrin 1 and claudin proteins. Conclusions Understanding the mechanisms underlying TROP2 signaling will clarify its role during development, aid in the development of better cancer treatments and unlock a promising new direction in regenerative medicine. Developmental Dynamics 244:99-109, 2015. (c) 2014 Wiley Periodicals, Inc. Key Findings
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available